By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Incyte Corporation 

Experimental Station
Route 141 & Henry Clay Road, Building E336
Wilmington  Delaware  19880  U.S.A.
Phone: 302-498-6700 Fax: 302-425-2750


Company News
Eli Lilly (LLY), Incyte Corporation (INCY) Arthritis Drug Meets Endpoint In Phase 3 12/9/2014 7:27:20 AM
Multiple Data Presentations At The 2014 American Society of Hematology Annual Meeting Showcase Incyte Corporation (INCY)'s Leadership In The Field Of Myeloproliferative Neoplasms (MPNs) 12/2/2014 9:11:25 AM
Incyte Corporation (INCY) To Present At Upcoming Investor Conferences 11/17/2014 5:23:37 PM
Sanofi (SAN.PA) And Incyte Corporation (INCY) Execs Exclusive: Future Hiring Trends And What They're Looking For In New Hires 11/4/2014 9:55:33 AM
BioMarin Pharmaceutical Inc. (BMRN),Incyte Corporation (INCY) Part Of Rally As Biotech Sector Booms, Says Cowen 11/3/2014 2:44:39 PM
Incyte Corporation (INCY) Reports 2014 Third-Quarter Financial Results And Updates Shareholders On Key Clinical Programs 10/30/2014 10:04:08 AM
Incyte Corporation (INCY) To Present At The Nomura Biopharma Conference 10/23/2014 11:40:09 AM
Incyte Corporation (INCY) Appoints David Gryska As Executive Vice President And Chief Financial Officer 10/17/2014 8:26:12 AM
Incyte Corporation (INCY) To Report Third Quarter 2014 Financial Results On October 30 10/15/2014 9:11:52 AM
Incyte Corporation (INCY) Pockets $60 Million Milestone Payment From Novartis AG (NVS) 10/2/2014 6:21:50 AM